Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Nov;66(2):303–311.

Pyrogenic and haematological effects of the interferon-inducing 22K factor (interleukin 1 beta) from human leukocytes.

J van Damme, G Opdenakker, M de Ley, H Heremans, A Billiau
PMCID: PMC1542544  PMID: 3493097

Abstract

Human 22K factor is a cytokine released by mitogen-stimulated peripheral blood leukocytes. The factor stimulates fibroblasts to produce interferon-beta (IFN-beta) and thereby exerts antiviral activity on these cells. It was identified as interleukin-1 beta (IL-1 beta) by its amino-acid sequence and spectrum of biological activities. The pyrogenic and haematological effects of pure 22K factor were studied at different doses and were compared with those of endotoxin and interferon. 22K factor dose-dependently induced fever in rabbits, 0.1 microgram/kg being a minimum effective dose. Intravenous injection in rabbits caused immediate granulocytosis at low dose, while a profound granulopenia followed by hypergranulocytosis was observed at high dose. Preparations of pure 22K factor were free of detectable lipopolysaccharide and lost their biological effects after heat-treatment. Repeated injections of 22K factor did not result in a state of tolerance. There is no evidence that the effects in vivo of 22K factor were mediated by induction of interferon. Human 22K factor, a weak and species-specific inducer in IFN-beta in vitro, did not induce detectable amounts of circulating interferon in rabbits. Moreover, injection of rabbits with IFN-beta resulted in a weak effect on body temperature and granulocyte counts as compared to similar doses of 22K factor.

Full text

PDF
307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman S. K., Hochstein H. D., Zoon K., Browne W., Rivera E., Elisberg B. Interferon fever: absence of human leukocytic pyrogen response to recombinant alpha-interferon. J Leukoc Biol. 1984 Jul;36(1):17–25. doi: 10.1002/jlb.36.1.17. [DOI] [PubMed] [Google Scholar]
  2. Bevilacqua M. P., Pober J. S., Wheeler M. E., Cotran R. S., Gimbrone M. A., Jr Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest. 1985 Nov;76(5):2003–2011. doi: 10.1172/JCI112200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Billiau A., De Somers P., Edy V. G., De Clercq E., Heremans H. Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans. Antimicrob Agents Chemother. 1979 Jul;16(1):56–63. doi: 10.1128/aac.16.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Billiau A., Joniau M., De Somer P. Mass production of human interferon in diploid cells stimulated by poly-I:C. J Gen Virol. 1973 Apr;19(1):1–8. doi: 10.1099/0022-1317-19-1-1. [DOI] [PubMed] [Google Scholar]
  5. Chervenick P. A., Boggs D. R. Granulocytic hyperplasia and induction of tolerance in response to chronic endotoxin administration. J Reticuloendothel Soc. 1971 Mar;9(3):288–297. [PubMed] [Google Scholar]
  6. Dinarello C. A., Bernheim H. A., Duff G. W., Le H. V., Nagabhushan T. L., Hamilton N. C., Coceani F. Mechanisms of fever induced by recombinant human interferon. J Clin Invest. 1984 Sep;74(3):906–913. doi: 10.1172/JCI111508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dinarello C. A. Interleukin-1. Rev Infect Dis. 1984 Jan-Feb;6(1):51–95. doi: 10.1093/clinids/6.1.51. [DOI] [PubMed] [Google Scholar]
  8. Durum S. K., Schmidt J. A., Oppenheim J. J. Interleukin 1: an immunological perspective. Annu Rev Immunol. 1985;3:263–287. doi: 10.1146/annurev.iy.03.040185.001403. [DOI] [PubMed] [Google Scholar]
  9. Heine J. W., Van Damme J., de Ley M., Billiau A., de Somer P. Purification of human fibroblast interferon by zinc chelate chromatography. J Gen Virol. 1981 May;54(Pt 1):47–56. doi: 10.1099/0022-1317-54-1-47. [DOI] [PubMed] [Google Scholar]
  10. Kampschmidt R. F. The numerous postulated biological manifestations of interleukin-1. J Leukoc Biol. 1984 Sep;36(3):341–355. doi: 10.1002/jlb.36.3.341. [DOI] [PubMed] [Google Scholar]
  11. Kampschmidt R. F., Upchurch H. F. Neutrophil release after injections of endotoxin or leukocytic endogenous mediator into rats. J Reticuloendothel Soc. 1980 Aug;28(2):191–201. [PubMed] [Google Scholar]
  12. Kampschmidt R. F., Upchurch H. F. Possible involvement of leukocytic endogenous mediator in granulopoiesis. Proc Soc Exp Biol Med. 1977 May;155(1):89–93. doi: 10.3181/00379727-155-39751. [DOI] [PubMed] [Google Scholar]
  13. Lucero M. A., Magdelenat H., Fridman W. H., Pouillart P., Billardon C., Billiau A., Cantell K., Falcoff E. Comparison of effects of leukocyte and fibroblast interferon on immunological parameters in cancer patients. Eur J Cancer Clin Oncol. 1982 Mar;18(3):243–251. doi: 10.1016/0277-5379(82)90043-8. [DOI] [PubMed] [Google Scholar]
  14. March C. J., Mosley B., Larsen A., Cerretti D. P., Braedt G., Price V., Gillis S., Henney C. S., Kronheim S. R., Grabstein K. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature. 1985 Jun 20;315(6021):641–647. doi: 10.1038/315641a0. [DOI] [PubMed] [Google Scholar]
  15. Matsushima K., Durum S. K., Kimball E. S., Oppenheim J. J. Purification of human interleukin 1 from human monocyte culture supernatants and identity of thymocyte comitogenic factor, fibroblast-proliferation factor, acute-phase protein-inducing factor, and endogenous pyrogen. Cell Immunol. 1985 May;92(2):290–301. doi: 10.1016/0008-8749(85)90010-3. [DOI] [PubMed] [Google Scholar]
  16. Van Damme J., De Ley M., Opdenakker G., Billiau A., De Somer P., Van Beeumen J. Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. Nature. 1985 Mar 21;314(6008):266–268. doi: 10.1038/314266a0. [DOI] [PubMed] [Google Scholar]
  17. Van Damme J., Opdenakker G., Billiau A., De Somer P., De Wit L., Poupart P., Content J. Stimulation of fibroblast interferon production by a 22K protein from human leukocytes. J Gen Virol. 1985 Apr;66(Pt 4):693–700. doi: 10.1099/0022-1317-66-4-693. [DOI] [PubMed] [Google Scholar]
  18. Wood D. D., Bayne E. K., Goldring M. B., Gowen M., Hamerman D., Humes J. L., Ihrie E. J., Lipsky P. E., Staruch M. J. The four biochemically distinct species of human interleukin 1 all exhibit similar biologic activities. J Immunol. 1985 Feb;134(2):895–903. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES